Prognostic role of body composition in peritoneal carcinomatosis patients undergoing cytoreduction and hyperthermic intraperitoneal chemotherapy

Table 4 Predictive power of selective variables including BIA parameters for 1-year mortality

	1-year mortality (N = 13/99)
	Univariate		Multivariate
	OR (95% CI)	p-value	OR (95% CI)	p-value
Age	1.002 (0.955–1.051)	0.937
Hypertension	1.679 (0.463–6.083)	0.430
Diabetes mellitus	0.813 (0.093–7.087)	0.851
ECOG PS	0.896 (0.449–1.789)	0.756
Preoperative albumin	0.946 (0.302–2.964)	0.924
BIA parameters
Protein	1.162 (0.847–1.594)	0.351
Fat	0.973 (0.895–1.058)	0.526
Mineral	1.683 (0.676–4.194)	0.263
Skeletal muscle mass	1.052 (0.947–1.168)	0.342
TBW/FFM	0.720 (0.133–3.898)	0.703
PhA	1.071 (0.573–1.999)	0.831
Intraoperative PCI > 20	4.750 (1.342–16.807)	0.016	4.489 (1.191–16.917)	0.027
30-day major postoperative complications	2.925 (0.665–12.865)	0.156	1.469 (0.269–8.007)	0.657
30-day postoperative re-admission	6.514 (1.822–23.295)	0.004	5.269 (1.288–21.547)	0.021

Values are presented as odds ratios (95% confidence intervals)
OR odds ratio, CI confidence interval, ECOG PS European Cooperative Oncology Group Performance Status, BIA bioelectric impedance analysis, TBW/FFM total body water/fat-free mass, PhA, phase angle; PCI, peritoneal cancer index

ISSN: 1477-7819